These outcomes, together with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two assist the thought of targeting ACKR3 as a novel method to modulate the opioid method, which could open up new therapeutic avenues for opioid-similar disorders. Title your selection: Name needs https://mohamedy950pfv4.wikievia.com/user